Evidence map›Paper›PMID 32766481›Full record

ArticleHepatology communications2020

#LiverTwitter: An Emerging Tool for Liver Education and Research.

Adam E Mikolajczyk, Nneka Ufere, Anthony C Breu, Neehar D Parikh, Guadalupe Garcia-Tsao, Elliot B Tapper

Abstract read
In one paragraph

Article in Hepatology communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Trial
  2. American Society for Gastrointestinal Endoscopy best practice statements on the sharing of endoscopic images and videos on social media.VideoGIE : an official video journal of the American Society for Gastrointestinal Endoscopy · 2024
    Article
  3. Article
  4. How to use social media for scientific advocacy and personal branding.United European gastroenterology journal · 2023
    Article
  5. Addressing the Burden and Management Strategies for Disparities and Inequities Among Liver Transplant Professionals: The ILTS Experience.Transplant international : official journal of the European Society for Organ Transplantation · 2023
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Embracing Progress and Unveiling Innovations.Journal of clinical and experimental hepatology
    Article
  11. Clinical liver disease
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Adam E MikolajczykUniversity of Illinois at Chicago Chicago IL.ORCID https://orcid.org/0000-0001-6002-6489
Nneka UfereMassachusetts General Hospital Boston MA.
Anthony C BreuVA Boston Medical System Boston MA.
Neehar D ParikhUniversity of Michigan Ann Arbor MI.ORCID https://orcid.org/0000-0002-5874-9933
Guadalupe Garcia-TsaoYale University New Haven CT.
Elliot B TapperUniversity of Michigan Ann Arbor MI.ORCID https://orcid.org/0000-0002-0839-1515

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

#LiverTwitter has emerged as an academic forum that has begun to advance the field of hepatology by disseminating content on chronic liver diseases to a global audience. This article summarizes the content presented in a panel discussion at the 2019 Liver Meeting by highlighting the perspectives of several key types of participants in Twitter: the trainee, the medical educator, the divisional account, the scientific journal, and the passive participant.

Identifiers

PMID32766481
PMCPMC7395060

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.